May 17, 2022 Comments Off on New patent for Millicent drug INTRAROSA Posted in: Patent Added Annual Drug Patent Expirations for INTRAROSA Intrarosa is a drug marketed by Millicent and is included in one NDA. There are three patents protecting this drug. INTRAROSA drug price trends.…
The post New patent for Millicent drug INTRAROSA appeared fir…
May 17, 2022 Comments Off on New patent for Genentech Inc drug ESBRIET Posted in: Patent Added Annual Drug Patent Expirations for ESBRIET Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier. There are twenty-one patents…
The post New patent for Genentech Inc drug ESBRIET appeared first on Dr…
